Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

blackmores ltd - magnesium phosphate pentahydrate,manganese amino acid chelate,pyridoxine hydrochloride,retinol acetate,zinc amino acid chelate -

Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

novotech australia pty ltd - mitozantrone hydrochloride -

Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

novotech australia pty ltd - mitozantrone hydrochloride -

Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

novotech australia pty ltd - mitozantrone hydrochloride -

Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - mitozantrone hydrochloride, quantity: 2.328 mg/ml (equivalent: mitozantrone, qty 2 mg/ml) - injection, concentrated - excipient ingredients: sodium chloride; glacial acetic acid; sodium acetate; water for injections - for the treament of: *locally advanced or metastatic carcinoma of the breast *non-hodgkin's lymphoma *adult acute non-lymphocytic leukaemia (anll) *chronic myelogenous leukaemia in blast crisis.

Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - mitozantrone hydrochloride, quantity: 2.328 mg/ml (equivalent: mitozantrone, qty 2 mg/ml) - injection, concentrated - excipient ingredients: sodium chloride; glacial acetic acid; sodium acetate; water for injections - for the treatment of: *locally advanced or metastatic carcinoma of the breast *non-hodgkin's lymphoma *adult acute non-lymphocytic leukaemia (anll) *chronic myelogenous leukaemia in blast crisis.

Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - mitozantrone hydrochloride, quantity: 2.328 mg/ml (equivalent: mitozantrone, qty 2 mg/ml) - injection, concentrated - excipient ingredients: sodium chloride; glacial acetic acid; sodium acetate; water for injections - for the treament of: *locally advanced or metastatic carcinoma of the breast *non-hodgkin's lymphoma *adult actue non-lymphocytic leukaemia (anll) *chronic myelogenous leukaemia in blast crisis.

Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - mitozantrone hydrochloride, quantity: 2.328 mg/ml (equivalent: mitozantrone, qty 2 mg/ml) - injection, concentrated - excipient ingredients: sodium chloride; glacial acetic acid; sodium acetate; water for injections - for the treatment of *locally advanced or metastatic carcinoma of the breast *non-hodgkin's lymphoma *adult acute non-lymphocytic leukaemia (anll) *chronic myelogenous leukaemia in blast crisis.